Jamie M. BennettAttorney
Jamie M. Bennett is the lead attorney in the Healthcare Fraud Law Group which she founded after a diverse career in private practice and government service. Ms. Bennett served for over twenty years as an Assistant United States Attorney in the United States Attorney’s Office (“USAO”) for the District of Maryland where she spent a decade investigating civil and criminal fraud claims on behalf of the United States under the False Claims Act. Before she joined the government, she spent six years with Hogan & Hartson (now Hogan Lovells) representing clients in case ranging from franchise litigation to national insurance coverage disputes. After leaving government service she joined Ashcraft & Gerel, where she represented relators in False Claims Act (“FCA”) cases. Ms. Bennett was or is lead or co-counsel on cases that have been litigated by her clients on behalf of the United States under the False Claims Act across the country, including United States ex rel Barker v. Columbus Regional Healthcare System (Georgia); United States ex rel Kerr v. APS Healthcare (Nevada) United States ex rel. Warder v. Shaw Environmental Group (Louisiana); United States ex rel. Whipple v. Chattanooga Hospital-Hamilton Hospital Authority (Tennessee) and United States ex rel Emanuele v. Hamot Hospital (Pennsylvania). Ms. Bennett specializes in healthcare fraud cases, particularly cases that involve allegations of violations of the Stark Law and the Antikickback Statute. She also has handled a number of SEC whistleblower complaints under the Dodd-Frank Act.
Ms. Bennett is a regular speaker on the lecture circuit, having appeared at the American Health Lawyers Association, American Conference Institute and Taxpayers Against Fraud conferences, among others. Most recently, Ms. Bennett has lectured on the preservation and waiver of attorney client privilege in FCA cases, and recent developments in the calculation of damages under the FCA. Her work as a prosecutor has been featured in national publications. Ms Bennett was interviewed by PBS for a piece on healthcare fraud in hospitals that aired in December 2011. She has tried over fifty cases in federal court, including both civil and criminal cases, and has appeared as lead counsel in appeals to the Fourth and Sixth Circuits. Ms. Bennett recently argued and won a significant appeal in Chattanooga-Hamilton Hospital Authority v. United States ex rel. Whipple, a case involving the definition of a “public disclosure” under the FCA’s jurisdictional bar.
While in government, Ms. Bennett’s successful investigations led to a $42.5 million settlement in 2009 of Anti-Kickback allegations with Alpharma Pharmaceuticals, Inc., a 2010 settlement with St. Joseph Medical Center, resolving claims that SJMC paid kickbacks to a prominent cardiology group in return for the referral of cardiac patients to the hospital and a $95 million settlement with Boehringer Ingelheim Pharmaceuticals involving off-label promotion of a number of the Company’s drugs. Before she became a member of the USAO’s civil frauds enforcement unit, Ms. Bennett was assigned to the Narcotics Division where she prosecuted drug and drug-related murder cases, including the first federal death penalty case in Maryland.
Ms. Bennett is a graduate of Georgetown University Law Center and the University of Rochester. In 2010 she received the United States Attorney’s top award for excellence in the prosecution of fraud for her work in the Alpharma and St. Joseph Medical Center investigations, among others.